pharmaobservatory 0.1.6 → 0.1.8
This diff represents the content of publicly available package versions that have been released to one of the supported registries. The information contained in this diff is provided for informational purposes only and reflects changes between package versions as they appear in their respective public registries.
- checksums.yaml +4 -4
- data/README.md +348 -4
- data/docs/BiomarkerAlleleFrequenciesResponse.md +58 -0
- data/docs/BiomarkerAlleleFrequenciesRow.md +62 -0
- data/docs/BiomarkerAssayProvidersResponse.md +58 -0
- data/docs/BiomarkerAssayProvidersRow.md +72 -0
- data/docs/BiomarkerEvidenceByYearResponse.md +58 -0
- data/docs/BiomarkerEvidenceByYearRow.md +32 -0
- data/docs/BiomarkerTraversalStatusResponse.md +58 -0
- data/docs/BiomarkerTraversalStatusRow.md +36 -0
- data/docs/BiomarkersApi.md +320 -0
- data/docs/BrandCompaniesResponse.md +58 -0
- data/docs/BrandCompaniesRow.md +50 -0
- data/docs/BrandRevenueResponse.md +58 -0
- data/docs/BrandRevenueRow.md +60 -0
- data/docs/CatalystsResponse.md +58 -0
- data/docs/CatalystsRow.md +90 -0
- data/docs/CliaCertificatesResponse.md +58 -0
- data/docs/CliaCertificatesRow.md +80 -0
- data/docs/CompaniesApi.md +2656 -196
- data/docs/CompaniesRecordAttributes.md +3 -1
- data/docs/CompanyAssetsRow.md +5 -1
- data/docs/CompanyBiomarkerCapabilityResponse.md +58 -0
- data/docs/CompanyBiomarkerCapabilityRow.md +68 -0
- data/docs/CompanyFundingEventsRow.md +2 -0
- data/docs/CompanyProgramsRow.md +5 -1
- data/docs/CompanyRareDiseaseDeclarationsResponse.md +58 -0
- data/docs/CompanyRareDiseaseDeclarationsRow.md +52 -0
- data/docs/CompanyTrialGeographyResponse.md +58 -0
- data/docs/CompanyTrialGeographyRow.md +52 -0
- data/docs/CompanyTrialSitesResponse.md +58 -0
- data/docs/CompanyTrialSitesRow.md +52 -0
- data/docs/ConditionsApi.md +320 -0
- data/docs/CroFootprintResponse.md +58 -0
- data/docs/CroFootprintRow.md +34 -0
- data/docs/CroTrialsResponse.md +58 -0
- data/docs/CroTrialsRow.md +46 -0
- data/docs/DebarmentsResponse.md +58 -0
- data/docs/DebarmentsRow.md +44 -0
- data/docs/DrugApprovalsResponse.md +58 -0
- data/docs/DrugApprovalsRow.md +28 -0
- data/docs/DrugAspCodesResponse.md +58 -0
- data/docs/DrugAspCodesRow.md +28 -0
- data/docs/DrugBrandsResponse.md +58 -0
- data/docs/DrugBrandsRow.md +60 -0
- data/docs/DrugCombinationsResponse.md +58 -0
- data/docs/DrugCombinationsRow.md +32 -0
- data/docs/DrugDeclaredPatentsResponse.md +58 -0
- data/docs/DrugDeclaredPatentsRow.md +58 -0
- data/docs/DrugLabelSafetyResponse.md +58 -0
- data/docs/DrugLabelSafetyRow.md +32 -0
- data/docs/DrugMedicareSpendResponse.md +58 -0
- data/docs/DrugMedicareSpendRow.md +28 -0
- data/docs/DrugPatentCliffRow.md +3 -1
- data/docs/DrugPatentMentionsResponse.md +58 -0
- data/docs/DrugPatentMentionsRow.md +28 -0
- data/docs/DrugPatentOwnersResponse.md +58 -0
- data/docs/DrugPatentOwnersRow.md +42 -0
- data/docs/DrugPricingResponse.md +58 -0
- data/docs/DrugPricingRow.md +32 -0
- data/docs/DrugRecallsResponse.md +58 -0
- data/docs/DrugRecallsRow.md +34 -0
- data/docs/DrugRegulatoryResponse.md +58 -0
- data/docs/DrugRegulatoryRow.md +38 -0
- data/docs/DrugSitesResponse.md +58 -0
- data/docs/DrugSitesRow.md +28 -0
- data/docs/DrugTargetsResponse.md +58 -0
- data/docs/DrugTargetsRow.md +36 -0
- data/docs/DrugTrialConditionsResponse.md +58 -0
- data/docs/DrugTrialConditionsRow.md +30 -0
- data/docs/DrugTrialsResponse.md +58 -0
- data/docs/DrugTrialsRow.md +58 -0
- data/docs/DrugVariantsResponse.md +58 -0
- data/docs/DrugVariantsRow.md +38 -0
- data/docs/DrugsApi.md +2153 -0
- data/docs/DrugsRecord.md +38 -0
- data/docs/DrugsRecordAttributes.md +20 -0
- data/docs/DrugsResponse.md +58 -0
- data/docs/DrugsRow.md +82 -0
- data/docs/EnforcementEventsResponse.md +58 -0
- data/docs/EnforcementEventsRow.md +64 -0
- data/docs/GxpFacilitiesResponse.md +58 -0
- data/docs/GxpFacilitiesRow.md +174 -0
- data/docs/HospitalBedsYearlyResponse.md +58 -0
- data/docs/HospitalBedsYearlyRow.md +28 -0
- data/docs/HospitalFacilityChangesResponse.md +58 -0
- data/docs/HospitalFacilityChangesRow.md +30 -0
- data/docs/HospitalsApi.md +393 -0
- data/docs/HospitalsRecord.md +38 -0
- data/docs/HospitalsResponse.md +58 -0
- data/docs/HospitalsRow.md +40 -0
- data/docs/ImportRefusalsResponse.md +58 -0
- data/docs/ImportRefusalsRow.md +60 -0
- data/docs/InspectionFindingsResponse.md +58 -0
- data/docs/InspectionFindingsRow.md +48 -0
- data/docs/InspectionsResponse.md +58 -0
- data/docs/InspectionsRow.md +60 -0
- data/docs/InstitutionalQuarterTotalsResponse.md +58 -0
- data/docs/InstitutionalQuarterTotalsRow.md +58 -0
- data/docs/LegalEntitiesApi.md +2257 -177
- data/docs/LegalEntitiesRecordAttributes.md +8 -0
- data/docs/LegalEntitySecFilingsResponse.md +58 -0
- data/docs/LegalEntitySecFilingsRow.md +44 -0
- data/docs/OrgDisclosureTrendResponse.md +58 -0
- data/docs/OrgDisclosureTrendRow.md +62 -0
- data/docs/OrgRelationshipsRow.md +1 -1
- data/docs/OwnershipPercentagesResponse.md +58 -0
- data/docs/OwnershipPercentagesRow.md +74 -0
- data/docs/OwnershipSourceCoverageResponse.md +58 -0
- data/docs/OwnershipSourceCoverageRow.md +62 -0
- data/docs/PdufaDatesRow.md +1 -1
- data/docs/ProgramLicensingCandidatesResponse.md +58 -0
- data/docs/ProgramLicensingCandidatesRow.md +62 -0
- data/docs/ProgramsResponse.md +58 -0
- data/docs/ProgramsRow.md +46 -0
- data/docs/RareDiseaseGenesResponse.md +58 -0
- data/docs/RareDiseaseGenesRow.md +50 -0
- data/docs/RareDiseaseHierarchyResponse.md +58 -0
- data/docs/RareDiseaseHierarchyRow.md +40 -0
- data/docs/RareDiseaseInvestigatorCoverageResponse.md +58 -0
- data/docs/RareDiseaseInvestigatorCoverageRow.md +38 -0
- data/docs/RareDiseaseInvestigatorsResponse.md +58 -0
- data/docs/RareDiseaseInvestigatorsRow.md +56 -0
- data/docs/RareDiseaseMappingsResponse.md +58 -0
- data/docs/RareDiseaseMappingsRow.md +44 -0
- data/docs/RareDiseaseOrganizationsResponse.md +58 -0
- data/docs/RareDiseaseOrganizationsRow.md +60 -0
- data/docs/RareDiseasePrevalenceResponse.md +58 -0
- data/docs/RareDiseasePrevalenceRow.md +62 -0
- data/docs/RareDiseaseRarityEvidenceResponse.md +58 -0
- data/docs/RareDiseaseRarityEvidenceRow.md +36 -0
- data/docs/RareDiseaseRarityResponse.md +58 -0
- data/docs/RareDiseaseRarityRow.md +54 -0
- data/docs/RareDiseaseReplacementsResponse.md +58 -0
- data/docs/RareDiseaseReplacementsRow.md +40 -0
- data/docs/RareDiseaseSiteCoverageResponse.md +58 -0
- data/docs/RareDiseaseSiteCoverageRow.md +54 -0
- data/docs/RareDiseaseSponsorsResponse.md +58 -0
- data/docs/RareDiseaseSponsorsRow.md +82 -0
- data/docs/RareDiseaseTrialCoverageResponse.md +58 -0
- data/docs/RareDiseaseTrialCoverageRow.md +58 -0
- data/docs/RareDiseaseTrialSitesResponse.md +58 -0
- data/docs/RareDiseaseTrialSitesRow.md +52 -0
- data/docs/RareDiseaseTrialsResponse.md +58 -0
- data/docs/RareDiseaseTrialsRow.md +90 -0
- data/docs/RareDiseasesApi.md +1353 -0
- data/docs/RareDiseasesRecord.md +38 -0
- data/docs/RareDiseasesRecordAttributes.md +22 -0
- data/docs/RareDiseasesResponse.md +58 -0
- data/docs/RareDiseasesRow.md +68 -0
- data/docs/RecallsResponse.md +58 -0
- data/docs/RecallsRow.md +54 -0
- data/docs/RwdConductorDeliveryResponse.md +58 -0
- data/docs/RwdConductorDeliveryRow.md +74 -0
- data/docs/RwdConductorFootprintResponse.md +58 -0
- data/docs/RwdConductorFootprintRow.md +40 -0
- data/docs/RwdConductorStudiesResponse.md +58 -0
- data/docs/RwdConductorStudiesRow.md +42 -0
- data/docs/RwdConductorsApi.md +393 -0
- data/docs/RwdConductorsRecord.md +38 -0
- data/docs/RwdConductorsResponse.md +58 -0
- data/docs/RwdConductorsRow.md +72 -0
- data/docs/RwdCoverageResponse.md +58 -0
- data/docs/RwdCoverageRow.md +52 -0
- data/docs/RwdInstitutionsApi.md +153 -0
- data/docs/RwdInstitutionsRecord.md +38 -0
- data/docs/RwdInstitutionsResponse.md +58 -0
- data/docs/RwdInstitutionsRow.md +154 -0
- data/docs/RwdNetworksApi.md +153 -0
- data/docs/RwdNetworksRecord.md +38 -0
- data/docs/RwdNetworksResponse.md +58 -0
- data/docs/RwdNetworksRow.md +110 -0
- data/docs/RwdRegisterProvenanceResponse.md +58 -0
- data/docs/RwdRegisterProvenanceRow.md +74 -0
- data/docs/RwdRegistersApi.md +313 -0
- data/docs/RwdRegistersRecord.md +38 -0
- data/docs/RwdSourceAgeBandsResponse.md +58 -0
- data/docs/RwdSourceAgeBandsRow.md +40 -0
- data/docs/RwdSourceConditionsResponse.md +58 -0
- data/docs/RwdSourceConditionsRow.md +68 -0
- data/docs/RwdSourceEtlMappingsResponse.md +58 -0
- data/docs/RwdSourceEtlMappingsRow.md +44 -0
- data/docs/RwdSourceLinkagesResponse.md +58 -0
- data/docs/RwdSourceLinkagesRow.md +64 -0
- data/docs/RwdSourceTypesResponse.md +58 -0
- data/docs/RwdSourceTypesRow.md +34 -0
- data/docs/RwdSourceVocabulariesResponse.md +58 -0
- data/docs/RwdSourceVocabulariesRow.md +42 -0
- data/docs/RwdSourcesApi.md +713 -0
- data/docs/RwdSourcesRecord.md +38 -0
- data/docs/RwdSourcesResponse.md +58 -0
- data/docs/RwdSourcesRow.md +280 -0
- data/docs/RwdStudiesApi.md +553 -0
- data/docs/RwdStudiesRecord.md +38 -0
- data/docs/RwdStudiesResponse.md +58 -0
- data/docs/RwdStudiesRow.md +180 -0
- data/docs/RwdStudyConditionsResponse.md +58 -0
- data/docs/RwdStudyConditionsRow.md +54 -0
- data/docs/RwdStudyDataSourcesResponse.md +58 -0
- data/docs/RwdStudyDataSourcesRow.md +54 -0
- data/docs/RwdStudyDrugsResponse.md +58 -0
- data/docs/RwdStudyDrugsRow.md +50 -0
- data/docs/RwdStudyMilestonesResponse.md +58 -0
- data/docs/RwdStudyMilestonesRow.md +54 -0
- data/docs/RwdWithheldFieldsResponse.md +58 -0
- data/docs/RwdWithheldFieldsRow.md +36 -0
- data/docs/SbtiCrosscheckResponse.md +58 -0
- data/docs/SbtiCrosscheckRow.md +48 -0
- data/docs/SecPdufaDatesResponse.md +58 -0
- data/docs/SecPdufaDatesRow.md +64 -0
- data/docs/SponsorDeliveryResponse.md +58 -0
- data/docs/SponsorDeliveryRow.md +52 -0
- data/docs/SponsorPatentMentionsResponse.md +58 -0
- data/docs/SponsorPatentMentionsRow.md +42 -0
- data/docs/SponsorTrialConditionsResponse.md +58 -0
- data/docs/SponsorTrialConditionsRow.md +36 -0
- data/docs/SponsorTrialDrugsResponse.md +58 -0
- data/docs/SponsorTrialDrugsRow.md +34 -0
- data/docs/TrialChangesRow.md +5 -1
- data/docs/TrialsApi.md +80 -0
- data/docs/TrialsRow.md +9 -1
- data/docs/UnmatchedProductRevenueResponse.md +58 -0
- data/docs/UnmatchedProductRevenueRow.md +80 -0
- data/docs/UntitledLettersResponse.md +58 -0
- data/docs/UntitledLettersRow.md +44 -0
- data/docs/WarningLettersResponse.md +58 -0
- data/docs/WarningLettersRow.md +50 -0
- data/lib/pharmaobservatory/api/biomarkers_api.rb +336 -0
- data/lib/pharmaobservatory/api/companies_api.rb +3026 -296
- data/lib/pharmaobservatory/api/conditions_api.rb +336 -0
- data/lib/pharmaobservatory/api/drugs_api.rb +2261 -0
- data/lib/pharmaobservatory/api/hospitals_api.rb +413 -0
- data/lib/pharmaobservatory/api/legal_entities_api.rb +2376 -192
- data/lib/pharmaobservatory/api/rare_diseases_api.rb +1421 -0
- data/lib/pharmaobservatory/api/rwd_conductors_api.rb +413 -0
- data/lib/pharmaobservatory/api/rwd_institutions_api.rb +161 -0
- data/lib/pharmaobservatory/api/rwd_networks_api.rb +161 -0
- data/lib/pharmaobservatory/api/rwd_registers_api.rb +329 -0
- data/lib/pharmaobservatory/api/rwd_sources_api.rb +749 -0
- data/lib/pharmaobservatory/api/rwd_studies_api.rb +581 -0
- data/lib/pharmaobservatory/api/trials_api.rb +84 -0
- data/lib/pharmaobservatory/models/biomarker_allele_frequencies_response.rb +478 -0
- data/lib/pharmaobservatory/models/biomarker_allele_frequencies_row.rb +465 -0
- data/lib/pharmaobservatory/models/biomarker_assay_providers_response.rb +478 -0
- data/lib/pharmaobservatory/models/biomarker_assay_providers_row.rb +520 -0
- data/lib/pharmaobservatory/models/biomarker_evidence_by_year_response.rb +478 -0
- data/lib/pharmaobservatory/models/biomarker_evidence_by_year_row.rb +300 -0
- data/lib/pharmaobservatory/models/biomarker_traversal_status_response.rb +478 -0
- data/lib/pharmaobservatory/models/biomarker_traversal_status_row.rb +322 -0
- data/lib/pharmaobservatory/models/brand_companies_response.rb +478 -0
- data/lib/pharmaobservatory/models/brand_companies_row.rb +401 -0
- data/lib/pharmaobservatory/models/brand_revenue_response.rb +478 -0
- data/lib/pharmaobservatory/models/brand_revenue_row.rb +454 -0
- data/lib/pharmaobservatory/models/catalysts_response.rb +478 -0
- data/lib/pharmaobservatory/models/catalysts_row.rb +623 -0
- data/lib/pharmaobservatory/models/clia_certificates_response.rb +478 -0
- data/lib/pharmaobservatory/models/clia_certificates_row.rb +568 -0
- data/lib/pharmaobservatory/models/companies_record_attributes.rb +13 -4
- data/lib/pharmaobservatory/models/company_assets_row.rb +24 -2
- data/lib/pharmaobservatory/models/company_biomarker_capability_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_biomarker_capability_row.rb +498 -0
- data/lib/pharmaobservatory/models/company_funding_events_row.rb +12 -1
- data/lib/pharmaobservatory/models/company_programs_row.rb +24 -2
- data/lib/pharmaobservatory/models/company_rare_disease_declarations_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_rare_disease_declarations_row.rb +410 -0
- data/lib/pharmaobservatory/models/company_trial_geography_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_trial_geography_row.rb +410 -0
- data/lib/pharmaobservatory/models/company_trial_sites_response.rb +478 -0
- data/lib/pharmaobservatory/models/company_trial_sites_row.rb +410 -0
- data/lib/pharmaobservatory/models/cro_footprint_response.rb +478 -0
- data/lib/pharmaobservatory/models/cro_footprint_row.rb +311 -0
- data/lib/pharmaobservatory/models/cro_trials_response.rb +478 -0
- data/lib/pharmaobservatory/models/cro_trials_row.rb +381 -0
- data/lib/pharmaobservatory/models/debarments_response.rb +478 -0
- data/lib/pharmaobservatory/models/debarments_row.rb +366 -0
- data/lib/pharmaobservatory/models/drug_approvals_response.rb +478 -0
- data/lib/pharmaobservatory/models/drug_approvals_row.rb +278 -0
- data/lib/pharmaobservatory/models/drug_asp_codes_response.rb +478 -0
- data/lib/pharmaobservatory/models/drug_asp_codes_row.rb +278 -0
- data/lib/pharmaobservatory/models/drug_brands_response.rb +478 -0
- data/lib/pharmaobservatory/models/drug_brands_row.rb +454 -0
- data/lib/pharmaobservatory/models/drug_combinations_response.rb +478 -0
- data/lib/pharmaobservatory/models/drug_combinations_row.rb +300 -0
- data/lib/pharmaobservatory/models/drug_declared_patents_response.rb +478 -0
- data/lib/pharmaobservatory/models/drug_declared_patents_row.rb +447 -0
- data/lib/pharmaobservatory/models/drug_label_safety_response.rb +478 -0
- data/lib/pharmaobservatory/models/drug_label_safety_row.rb +300 -0
- data/lib/pharmaobservatory/models/drug_medicare_spend_response.rb +478 -0
- data/lib/pharmaobservatory/models/drug_medicare_spend_row.rb +280 -0
- data/lib/pharmaobservatory/models/drug_patent_cliff_row.rb +13 -2
- data/lib/pharmaobservatory/models/drug_patent_mentions_response.rb +478 -0
- data/lib/pharmaobservatory/models/drug_patent_mentions_row.rb +278 -0
- data/lib/pharmaobservatory/models/drug_patent_owners_response.rb +478 -0
- data/lib/pharmaobservatory/models/drug_patent_owners_row.rb +357 -0
- data/lib/pharmaobservatory/models/drug_pricing_response.rb +478 -0
- data/lib/pharmaobservatory/models/drug_pricing_row.rb +300 -0
- data/lib/pharmaobservatory/models/drug_recalls_response.rb +478 -0
- data/lib/pharmaobservatory/models/drug_recalls_row.rb +311 -0
- data/lib/pharmaobservatory/models/drug_regulatory_response.rb +478 -0
- data/lib/pharmaobservatory/models/drug_regulatory_row.rb +333 -0
- data/lib/pharmaobservatory/models/drug_sites_response.rb +478 -0
- data/lib/pharmaobservatory/models/drug_sites_row.rb +278 -0
- data/lib/pharmaobservatory/models/drug_targets_response.rb +478 -0
- data/lib/pharmaobservatory/models/drug_targets_row.rb +324 -0
- data/lib/pharmaobservatory/models/drug_trial_conditions_response.rb +478 -0
- data/lib/pharmaobservatory/models/drug_trial_conditions_row.rb +289 -0
- data/lib/pharmaobservatory/models/drug_trials_response.rb +478 -0
- data/lib/pharmaobservatory/models/drug_trials_row.rb +445 -0
- data/lib/pharmaobservatory/models/drug_variants_response.rb +478 -0
- data/lib/pharmaobservatory/models/drug_variants_row.rb +333 -0
- data/lib/pharmaobservatory/models/drugs_record.rb +385 -0
- data/lib/pharmaobservatory/models/drugs_record_attributes.rb +229 -0
- data/lib/pharmaobservatory/models/drugs_response.rb +478 -0
- data/lib/pharmaobservatory/models/drugs_row.rb +581 -0
- data/lib/pharmaobservatory/models/enforcement_events_response.rb +478 -0
- data/lib/pharmaobservatory/models/enforcement_events_row.rb +476 -0
- data/lib/pharmaobservatory/models/gxp_facilities_response.rb +478 -0
- data/lib/pharmaobservatory/models/gxp_facilities_row.rb +1089 -0
- data/lib/pharmaobservatory/models/hospital_beds_yearly_response.rb +478 -0
- data/lib/pharmaobservatory/models/hospital_beds_yearly_row.rb +278 -0
- data/lib/pharmaobservatory/models/hospital_facility_changes_response.rb +478 -0
- data/lib/pharmaobservatory/models/hospital_facility_changes_row.rb +289 -0
- data/lib/pharmaobservatory/models/hospitals_record.rb +385 -0
- data/lib/pharmaobservatory/models/hospitals_response.rb +478 -0
- data/lib/pharmaobservatory/models/hospitals_row.rb +344 -0
- data/lib/pharmaobservatory/models/import_refusals_response.rb +478 -0
- data/lib/pharmaobservatory/models/import_refusals_row.rb +454 -0
- data/lib/pharmaobservatory/models/inspection_findings_response.rb +478 -0
- data/lib/pharmaobservatory/models/inspection_findings_row.rb +388 -0
- data/lib/pharmaobservatory/models/inspections_response.rb +478 -0
- data/lib/pharmaobservatory/models/inspections_row.rb +454 -0
- data/lib/pharmaobservatory/models/institutional_quarter_totals_response.rb +478 -0
- data/lib/pharmaobservatory/models/institutional_quarter_totals_row.rb +443 -0
- data/lib/pharmaobservatory/models/legal_entities_record_attributes.rb +37 -1
- data/lib/pharmaobservatory/models/legal_entity_sec_filings_response.rb +478 -0
- data/lib/pharmaobservatory/models/legal_entity_sec_filings_row.rb +370 -0
- data/lib/pharmaobservatory/models/org_disclosure_trend_response.rb +478 -0
- data/lib/pharmaobservatory/models/org_disclosure_trend_row.rb +465 -0
- data/lib/pharmaobservatory/models/org_relationships_row.rb +1 -1
- data/lib/pharmaobservatory/models/ownership_percentages_response.rb +478 -0
- data/lib/pharmaobservatory/models/ownership_percentages_row.rb +531 -0
- data/lib/pharmaobservatory/models/ownership_source_coverage_response.rb +478 -0
- data/lib/pharmaobservatory/models/ownership_source_coverage_row.rb +465 -0
- data/lib/pharmaobservatory/models/pdufa_dates_row.rb +1 -1
- data/lib/pharmaobservatory/models/program_licensing_candidates_response.rb +478 -0
- data/lib/pharmaobservatory/models/program_licensing_candidates_row.rb +467 -0
- data/lib/pharmaobservatory/models/programs_response.rb +478 -0
- data/lib/pharmaobservatory/models/programs_row.rb +377 -0
- data/lib/pharmaobservatory/models/rare_disease_genes_response.rb +478 -0
- data/lib/pharmaobservatory/models/rare_disease_genes_row.rb +399 -0
- data/lib/pharmaobservatory/models/rare_disease_hierarchy_response.rb +478 -0
- data/lib/pharmaobservatory/models/rare_disease_hierarchy_row.rb +344 -0
- data/lib/pharmaobservatory/models/rare_disease_investigator_coverage_response.rb +478 -0
- data/lib/pharmaobservatory/models/rare_disease_investigator_coverage_row.rb +333 -0
- data/lib/pharmaobservatory/models/rare_disease_investigators_response.rb +478 -0
- data/lib/pharmaobservatory/models/rare_disease_investigators_row.rb +436 -0
- data/lib/pharmaobservatory/models/rare_disease_mappings_response.rb +478 -0
- data/lib/pharmaobservatory/models/rare_disease_mappings_row.rb +366 -0
- data/lib/pharmaobservatory/models/rare_disease_organizations_response.rb +478 -0
- data/lib/pharmaobservatory/models/rare_disease_organizations_row.rb +454 -0
- data/lib/pharmaobservatory/models/rare_disease_prevalence_response.rb +478 -0
- data/lib/pharmaobservatory/models/rare_disease_prevalence_row.rb +465 -0
- data/lib/pharmaobservatory/models/rare_disease_rarity_evidence_response.rb +478 -0
- data/lib/pharmaobservatory/models/rare_disease_rarity_evidence_row.rb +322 -0
- data/lib/pharmaobservatory/models/rare_disease_rarity_response.rb +478 -0
- data/lib/pharmaobservatory/models/rare_disease_rarity_row.rb +421 -0
- data/lib/pharmaobservatory/models/rare_disease_replacements_response.rb +478 -0
- data/lib/pharmaobservatory/models/rare_disease_replacements_row.rb +344 -0
- data/lib/pharmaobservatory/models/rare_disease_site_coverage_response.rb +478 -0
- data/lib/pharmaobservatory/models/rare_disease_site_coverage_row.rb +421 -0
- data/lib/pharmaobservatory/models/rare_disease_sponsors_response.rb +478 -0
- data/lib/pharmaobservatory/models/rare_disease_sponsors_row.rb +575 -0
- data/lib/pharmaobservatory/models/rare_disease_trial_coverage_response.rb +478 -0
- data/lib/pharmaobservatory/models/rare_disease_trial_coverage_row.rb +449 -0
- data/lib/pharmaobservatory/models/rare_disease_trial_sites_response.rb +478 -0
- data/lib/pharmaobservatory/models/rare_disease_trial_sites_row.rb +412 -0
- data/lib/pharmaobservatory/models/rare_disease_trials_response.rb +478 -0
- data/lib/pharmaobservatory/models/rare_disease_trials_row.rb +623 -0
- data/lib/pharmaobservatory/models/rare_diseases_record.rb +385 -0
- data/lib/pharmaobservatory/models/rare_diseases_record_attributes.rb +238 -0
- data/lib/pharmaobservatory/models/rare_diseases_response.rb +478 -0
- data/lib/pharmaobservatory/models/rare_diseases_row.rb +500 -0
- data/lib/pharmaobservatory/models/recalls_response.rb +478 -0
- data/lib/pharmaobservatory/models/recalls_row.rb +421 -0
- data/lib/pharmaobservatory/models/rwd_conductor_delivery_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_conductor_delivery_row.rb +537 -0
- data/lib/pharmaobservatory/models/rwd_conductor_footprint_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_conductor_footprint_row.rb +346 -0
- data/lib/pharmaobservatory/models/rwd_conductor_studies_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_conductor_studies_row.rb +355 -0
- data/lib/pharmaobservatory/models/rwd_conductors_record.rb +385 -0
- data/lib/pharmaobservatory/models/rwd_conductors_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_conductors_row.rb +526 -0
- data/lib/pharmaobservatory/models/rwd_coverage_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_coverage_row.rb +410 -0
- data/lib/pharmaobservatory/models/rwd_institutions_record.rb +385 -0
- data/lib/pharmaobservatory/models/rwd_institutions_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_institutions_row.rb +981 -0
- data/lib/pharmaobservatory/models/rwd_networks_record.rb +385 -0
- data/lib/pharmaobservatory/models/rwd_networks_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_networks_row.rb +733 -0
- data/lib/pharmaobservatory/models/rwd_register_provenance_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_register_provenance_row.rb +531 -0
- data/lib/pharmaobservatory/models/rwd_registers_record.rb +385 -0
- data/lib/pharmaobservatory/models/rwd_source_age_bands_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_source_age_bands_row.rb +344 -0
- data/lib/pharmaobservatory/models/rwd_source_conditions_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_source_conditions_row.rb +502 -0
- data/lib/pharmaobservatory/models/rwd_source_etl_mappings_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_source_etl_mappings_row.rb +366 -0
- data/lib/pharmaobservatory/models/rwd_source_linkages_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_source_linkages_row.rb +476 -0
- data/lib/pharmaobservatory/models/rwd_source_types_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_source_types_row.rb +311 -0
- data/lib/pharmaobservatory/models/rwd_source_vocabularies_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_source_vocabularies_row.rb +355 -0
- data/lib/pharmaobservatory/models/rwd_sources_record.rb +385 -0
- data/lib/pharmaobservatory/models/rwd_sources_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_sources_row.rb +1674 -0
- data/lib/pharmaobservatory/models/rwd_studies_record.rb +385 -0
- data/lib/pharmaobservatory/models/rwd_studies_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_studies_row.rb +1138 -0
- data/lib/pharmaobservatory/models/rwd_study_conditions_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_study_conditions_row.rb +421 -0
- data/lib/pharmaobservatory/models/rwd_study_data_sources_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_study_data_sources_row.rb +423 -0
- data/lib/pharmaobservatory/models/rwd_study_drugs_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_study_drugs_row.rb +401 -0
- data/lib/pharmaobservatory/models/rwd_study_milestones_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_study_milestones_row.rb +421 -0
- data/lib/pharmaobservatory/models/rwd_withheld_fields_response.rb +478 -0
- data/lib/pharmaobservatory/models/rwd_withheld_fields_row.rb +322 -0
- data/lib/pharmaobservatory/models/sbti_crosscheck_response.rb +478 -0
- data/lib/pharmaobservatory/models/sbti_crosscheck_row.rb +388 -0
- data/lib/pharmaobservatory/models/sec_pdufa_dates_response.rb +478 -0
- data/lib/pharmaobservatory/models/sec_pdufa_dates_row.rb +476 -0
- data/lib/pharmaobservatory/models/sponsor_delivery_response.rb +478 -0
- data/lib/pharmaobservatory/models/sponsor_delivery_row.rb +410 -0
- data/lib/pharmaobservatory/models/sponsor_patent_mentions_response.rb +478 -0
- data/lib/pharmaobservatory/models/sponsor_patent_mentions_row.rb +355 -0
- data/lib/pharmaobservatory/models/sponsor_trial_conditions_response.rb +478 -0
- data/lib/pharmaobservatory/models/sponsor_trial_conditions_row.rb +322 -0
- data/lib/pharmaobservatory/models/sponsor_trial_drugs_response.rb +478 -0
- data/lib/pharmaobservatory/models/sponsor_trial_drugs_row.rb +311 -0
- data/lib/pharmaobservatory/models/trial_changes_row.rb +24 -2
- data/lib/pharmaobservatory/models/trials_row.rb +47 -3
- data/lib/pharmaobservatory/models/unmatched_product_revenue_response.rb +478 -0
- data/lib/pharmaobservatory/models/unmatched_product_revenue_row.rb +564 -0
- data/lib/pharmaobservatory/models/untitled_letters_response.rb +478 -0
- data/lib/pharmaobservatory/models/untitled_letters_row.rb +366 -0
- data/lib/pharmaobservatory/models/warning_letters_response.rb +478 -0
- data/lib/pharmaobservatory/models/warning_letters_row.rb +399 -0
- data/lib/pharmaobservatory/version.rb +1 -1
- data/lib/pharmaobservatory.rb +210 -0
- metadata +422 -2
|
@@ -0,0 +1,36 @@
|
|
|
1
|
+
# PharmaObservatory::DrugTargetsRow
|
|
2
|
+
|
|
3
|
+
## Properties
|
|
4
|
+
|
|
5
|
+
| Name | Type | Description | Notes |
|
|
6
|
+
| ---- | ---- | ----------- | ----- |
|
|
7
|
+
| **molecule_id** | **String** | The molecule key: the resolved drug a brand, a salt form or an investigational arm resolves to, and the entry key for the drugs object type. A member id (a salt or a folded trial arm) is not a value here; it redirects to its molecule. | [optional] |
|
|
8
|
+
| **ensembl_id** | **String** | The target's Ensembl gene id: the entry key of the targets object type. | [optional] |
|
|
9
|
+
| **symbol** | **String** | The gene symbol: the route key of the biomarker page for the same gene. | [optional] |
|
|
10
|
+
| **target_name** | **String** | The target's name. | [optional] |
|
|
11
|
+
| **uniprot** | **String** | The UniProt accession of the target protein. | [optional] |
|
|
12
|
+
| **has_pdb** | **Boolean** | True when the Protein Data Bank holds a structure for the protein. | [optional] |
|
|
13
|
+
| **primary_action_type** | **String** | The mechanism of action (for example INHIBITOR, AGONIST) from the best-ranked evidence that states one. | [optional] |
|
|
14
|
+
| **evidence_source** | **String** | The best-ranked evidence source for the link. | [optional] |
|
|
15
|
+
| **evidence_rank** | **Integer** | The rank of that source; lower is stronger. | [optional] |
|
|
16
|
+
| **evidence_sources** | **Array<String>** | Every evidence source for the link. | [optional] |
|
|
17
|
+
|
|
18
|
+
## Example
|
|
19
|
+
|
|
20
|
+
```ruby
|
|
21
|
+
require 'pharmaobservatory'
|
|
22
|
+
|
|
23
|
+
instance = PharmaObservatory::DrugTargetsRow.new(
|
|
24
|
+
molecule_id: null,
|
|
25
|
+
ensembl_id: null,
|
|
26
|
+
symbol: null,
|
|
27
|
+
target_name: null,
|
|
28
|
+
uniprot: null,
|
|
29
|
+
has_pdb: null,
|
|
30
|
+
primary_action_type: null,
|
|
31
|
+
evidence_source: null,
|
|
32
|
+
evidence_rank: null,
|
|
33
|
+
evidence_sources: null
|
|
34
|
+
)
|
|
35
|
+
```
|
|
36
|
+
|
|
@@ -0,0 +1,58 @@
|
|
|
1
|
+
# PharmaObservatory::DrugTrialConditionsResponse
|
|
2
|
+
|
|
3
|
+
## Properties
|
|
4
|
+
|
|
5
|
+
| Name | Type | Description | Notes |
|
|
6
|
+
| ---- | ---- | ----------- | ----- |
|
|
7
|
+
| **dataset** | **String** | | |
|
|
8
|
+
| **grain** | **String** | | [optional] |
|
|
9
|
+
| **object_type** | **String** | | [optional] |
|
|
10
|
+
| **id** | **String** | | [optional] |
|
|
11
|
+
| **scope** | [**BiomarkerAssayEvidenceResponseScope**](BiomarkerAssayEvidenceResponseScope.md) | | [optional] |
|
|
12
|
+
| **columns** | [**Array<DatasetColumn>**](DatasetColumn.md) | | |
|
|
13
|
+
| **rows** | [**Array<DrugTrialConditionsRow>**](DrugTrialConditionsRow.md) | | |
|
|
14
|
+
| **total** | **Integer** | The exact count of the filtered rows on an ungrouped read, carried by the cursor; null when grouped. | [optional] |
|
|
15
|
+
| **next_cursor** | **String** | | [optional] |
|
|
16
|
+
| **sort** | **Array<String>** | | [optional] |
|
|
17
|
+
| **filters** | **Array<Hash<String, Object>>** | | [optional] |
|
|
18
|
+
| **group_by** | **Array<String>** | | [optional] |
|
|
19
|
+
| **measures** | **Array<String>** | | [optional] |
|
|
20
|
+
| **attribution** | [**Array<DatasetAttribution>**](DatasetAttribution.md) | | [optional] |
|
|
21
|
+
| **source_credit** | **String** | | [optional] |
|
|
22
|
+
| **withheld_tiers** | **Array<String>** | | [optional] |
|
|
23
|
+
| **withheld_columns** | **Array<String>** | | [optional] |
|
|
24
|
+
| **freshness** | [**BiomarkerAssayEvidenceResponseFreshness**](BiomarkerAssayEvidenceResponseFreshness.md) | | [optional] |
|
|
25
|
+
| **build** | [**BiomarkerAssayEvidenceResponseBuild**](BiomarkerAssayEvidenceResponseBuild.md) | | [optional] |
|
|
26
|
+
| **build_state** | [**DatasetBuildState**](DatasetBuildState.md) | | [optional] |
|
|
27
|
+
| **restriction** | **Hash<String, Object>** | | [optional] |
|
|
28
|
+
|
|
29
|
+
## Example
|
|
30
|
+
|
|
31
|
+
```ruby
|
|
32
|
+
require 'pharmaobservatory'
|
|
33
|
+
|
|
34
|
+
instance = PharmaObservatory::DrugTrialConditionsResponse.new(
|
|
35
|
+
dataset: null,
|
|
36
|
+
grain: null,
|
|
37
|
+
object_type: null,
|
|
38
|
+
id: null,
|
|
39
|
+
scope: null,
|
|
40
|
+
columns: null,
|
|
41
|
+
rows: null,
|
|
42
|
+
total: null,
|
|
43
|
+
next_cursor: null,
|
|
44
|
+
sort: null,
|
|
45
|
+
filters: null,
|
|
46
|
+
group_by: null,
|
|
47
|
+
measures: null,
|
|
48
|
+
attribution: null,
|
|
49
|
+
source_credit: null,
|
|
50
|
+
withheld_tiers: null,
|
|
51
|
+
withheld_columns: null,
|
|
52
|
+
freshness: null,
|
|
53
|
+
build: null,
|
|
54
|
+
build_state: null,
|
|
55
|
+
restriction: null
|
|
56
|
+
)
|
|
57
|
+
```
|
|
58
|
+
|
|
@@ -0,0 +1,30 @@
|
|
|
1
|
+
# PharmaObservatory::DrugTrialConditionsRow
|
|
2
|
+
|
|
3
|
+
## Properties
|
|
4
|
+
|
|
5
|
+
| Name | Type | Description | Notes |
|
|
6
|
+
| ---- | ---- | ----------- | ----- |
|
|
7
|
+
| **molecule_id** | **String** | The molecule key: the resolved drug a brand, a salt form or an investigational arm resolves to, and the entry key for the drugs object type. A member id (a salt or a folded trial arm) is not a value here; it redirects to its molecule. | [optional] |
|
|
8
|
+
| **trial_id** | **String** | The trial's ClinicalTrials.gov registry id (NCT, National Clinical Trial, number). | [optional] |
|
|
9
|
+
| **condition_id** | **String** | The condition key (a MeSH, Medical Subject Headings, descriptor id). | [optional] |
|
|
10
|
+
| **condition_name** | **String** | The condition's name. | [optional] |
|
|
11
|
+
| **phase** | **String** | The registry's phase code of the trial. | [optional] |
|
|
12
|
+
| **phase_rank** | **Integer** | The trial's phase as a number for max and sort (4 is Phase 4, 0 is not reported). | [optional] |
|
|
13
|
+
| **overall_status_summary** | **String** | The trial's overall status grouped as Completed, Ongoing, Terminated or Other. | [optional] |
|
|
14
|
+
|
|
15
|
+
## Example
|
|
16
|
+
|
|
17
|
+
```ruby
|
|
18
|
+
require 'pharmaobservatory'
|
|
19
|
+
|
|
20
|
+
instance = PharmaObservatory::DrugTrialConditionsRow.new(
|
|
21
|
+
molecule_id: null,
|
|
22
|
+
trial_id: null,
|
|
23
|
+
condition_id: null,
|
|
24
|
+
condition_name: null,
|
|
25
|
+
phase: null,
|
|
26
|
+
phase_rank: null,
|
|
27
|
+
overall_status_summary: null
|
|
28
|
+
)
|
|
29
|
+
```
|
|
30
|
+
|
|
@@ -0,0 +1,58 @@
|
|
|
1
|
+
# PharmaObservatory::DrugTrialsResponse
|
|
2
|
+
|
|
3
|
+
## Properties
|
|
4
|
+
|
|
5
|
+
| Name | Type | Description | Notes |
|
|
6
|
+
| ---- | ---- | ----------- | ----- |
|
|
7
|
+
| **dataset** | **String** | | |
|
|
8
|
+
| **grain** | **String** | | [optional] |
|
|
9
|
+
| **object_type** | **String** | | [optional] |
|
|
10
|
+
| **id** | **String** | | [optional] |
|
|
11
|
+
| **scope** | [**BiomarkerAssayEvidenceResponseScope**](BiomarkerAssayEvidenceResponseScope.md) | | [optional] |
|
|
12
|
+
| **columns** | [**Array<DatasetColumn>**](DatasetColumn.md) | | |
|
|
13
|
+
| **rows** | [**Array<DrugTrialsRow>**](DrugTrialsRow.md) | | |
|
|
14
|
+
| **total** | **Integer** | The exact count of the filtered rows on an ungrouped read, carried by the cursor; null when grouped. | [optional] |
|
|
15
|
+
| **next_cursor** | **String** | | [optional] |
|
|
16
|
+
| **sort** | **Array<String>** | | [optional] |
|
|
17
|
+
| **filters** | **Array<Hash<String, Object>>** | | [optional] |
|
|
18
|
+
| **group_by** | **Array<String>** | | [optional] |
|
|
19
|
+
| **measures** | **Array<String>** | | [optional] |
|
|
20
|
+
| **attribution** | [**Array<DatasetAttribution>**](DatasetAttribution.md) | | [optional] |
|
|
21
|
+
| **source_credit** | **String** | | [optional] |
|
|
22
|
+
| **withheld_tiers** | **Array<String>** | | [optional] |
|
|
23
|
+
| **withheld_columns** | **Array<String>** | | [optional] |
|
|
24
|
+
| **freshness** | [**BiomarkerAssayEvidenceResponseFreshness**](BiomarkerAssayEvidenceResponseFreshness.md) | | [optional] |
|
|
25
|
+
| **build** | [**BiomarkerAssayEvidenceResponseBuild**](BiomarkerAssayEvidenceResponseBuild.md) | | [optional] |
|
|
26
|
+
| **build_state** | [**DatasetBuildState**](DatasetBuildState.md) | | [optional] |
|
|
27
|
+
| **restriction** | **Hash<String, Object>** | | [optional] |
|
|
28
|
+
|
|
29
|
+
## Example
|
|
30
|
+
|
|
31
|
+
```ruby
|
|
32
|
+
require 'pharmaobservatory'
|
|
33
|
+
|
|
34
|
+
instance = PharmaObservatory::DrugTrialsResponse.new(
|
|
35
|
+
dataset: null,
|
|
36
|
+
grain: null,
|
|
37
|
+
object_type: null,
|
|
38
|
+
id: null,
|
|
39
|
+
scope: null,
|
|
40
|
+
columns: null,
|
|
41
|
+
rows: null,
|
|
42
|
+
total: null,
|
|
43
|
+
next_cursor: null,
|
|
44
|
+
sort: null,
|
|
45
|
+
filters: null,
|
|
46
|
+
group_by: null,
|
|
47
|
+
measures: null,
|
|
48
|
+
attribution: null,
|
|
49
|
+
source_credit: null,
|
|
50
|
+
withheld_tiers: null,
|
|
51
|
+
withheld_columns: null,
|
|
52
|
+
freshness: null,
|
|
53
|
+
build: null,
|
|
54
|
+
build_state: null,
|
|
55
|
+
restriction: null
|
|
56
|
+
)
|
|
57
|
+
```
|
|
58
|
+
|
|
@@ -0,0 +1,58 @@
|
|
|
1
|
+
# PharmaObservatory::DrugTrialsRow
|
|
2
|
+
|
|
3
|
+
## Properties
|
|
4
|
+
|
|
5
|
+
| Name | Type | Description | Notes |
|
|
6
|
+
| ---- | ---- | ----------- | ----- |
|
|
7
|
+
| **molecule_id** | **String** | The molecule key: the resolved drug a brand, a salt form or an investigational arm resolves to, and the entry key for the drugs object type. A member id (a salt or a folded trial arm) is not a value here; it redirects to its molecule. | [optional] |
|
|
8
|
+
| **trial_id** | **String** | The trial's ClinicalTrials.gov registry id (NCT, National Clinical Trial, number). | [optional] |
|
|
9
|
+
| **title** | **String** | The trial's brief title. | [optional] |
|
|
10
|
+
| **phase** | **String** | The registry's phase code. Null when the registry gives no phase; phase_label carries the display label for those. | [optional] |
|
|
11
|
+
| **phase_label** | **String** | The trial phase as a display label (Phase 2, Phase 3, Observational, Not applicable, Expanded access, Unknown). | [optional] |
|
|
12
|
+
| **phase_rank** | **Integer** | The development phase as a number for max and sort: 4 is Phase 4, 3 is Phase 3 or 2/3, 2 is Phase 2 or 1/2, 1 is Phase 1 or Early Phase 1, 0 is not reported. | [optional] |
|
|
13
|
+
| **overall_status** | **String** | The registry's overall status. | [optional] |
|
|
14
|
+
| **overall_status_summary** | **String** | The overall status grouped as Completed, Ongoing, Terminated or Other. | [optional] |
|
|
15
|
+
| **study_type** | **String** | INTERVENTIONAL, OBSERVATIONAL or EXPANDED_ACCESS. | [optional] |
|
|
16
|
+
| **start_date** | **Date** | Trial start date. | [optional] |
|
|
17
|
+
| **primary_completion_date** | **Date** | The date primary data collection ends (estimated for an ongoing trial). | [optional] |
|
|
18
|
+
| **completion_date** | **Date** | The trial's completion date (estimated for an ongoing trial). | [optional] |
|
|
19
|
+
| **enrollment** | **Integer** | Enrollment as registered for the whole trial. | [optional] |
|
|
20
|
+
| **has_results** | **Boolean** | True when the sponsor has posted results to the registry. | [optional] |
|
|
21
|
+
| **lead_sponsor_name** | **String** | The lead sponsor's name as filed. | [optional] |
|
|
22
|
+
| **lead_sponsor_org_id** | **String** | Legal-entity level: the organization record the lead sponsor resolved to (null when unresolved). | [optional] |
|
|
23
|
+
| **lead_sponsor_company_id** | **String** | Company level: the lead sponsor's company (null when unresolved). | [optional] |
|
|
24
|
+
| **lead_sponsor_company_name** | **String** | Display name of the lead sponsor's company. | [optional] |
|
|
25
|
+
| **lead_sponsor_group_id** | **String** | Group level: the lead sponsor's current ultimate parent company; a root company's group is itself. | [optional] |
|
|
26
|
+
| **lead_sponsor_group_name** | **String** | Display name of the lead sponsor's group. | [optional] |
|
|
27
|
+
| **condition_ids** | **Array<String>** | The condition keys (MeSH, Medical Subject Headings, descriptor ids) the trial studies; drug_trial_conditions has one row per specific indication. | [optional] |
|
|
28
|
+
|
|
29
|
+
## Example
|
|
30
|
+
|
|
31
|
+
```ruby
|
|
32
|
+
require 'pharmaobservatory'
|
|
33
|
+
|
|
34
|
+
instance = PharmaObservatory::DrugTrialsRow.new(
|
|
35
|
+
molecule_id: null,
|
|
36
|
+
trial_id: null,
|
|
37
|
+
title: null,
|
|
38
|
+
phase: null,
|
|
39
|
+
phase_label: null,
|
|
40
|
+
phase_rank: null,
|
|
41
|
+
overall_status: null,
|
|
42
|
+
overall_status_summary: null,
|
|
43
|
+
study_type: null,
|
|
44
|
+
start_date: null,
|
|
45
|
+
primary_completion_date: null,
|
|
46
|
+
completion_date: null,
|
|
47
|
+
enrollment: null,
|
|
48
|
+
has_results: null,
|
|
49
|
+
lead_sponsor_name: null,
|
|
50
|
+
lead_sponsor_org_id: null,
|
|
51
|
+
lead_sponsor_company_id: null,
|
|
52
|
+
lead_sponsor_company_name: null,
|
|
53
|
+
lead_sponsor_group_id: null,
|
|
54
|
+
lead_sponsor_group_name: null,
|
|
55
|
+
condition_ids: null
|
|
56
|
+
)
|
|
57
|
+
```
|
|
58
|
+
|
|
@@ -0,0 +1,58 @@
|
|
|
1
|
+
# PharmaObservatory::DrugVariantsResponse
|
|
2
|
+
|
|
3
|
+
## Properties
|
|
4
|
+
|
|
5
|
+
| Name | Type | Description | Notes |
|
|
6
|
+
| ---- | ---- | ----------- | ----- |
|
|
7
|
+
| **dataset** | **String** | | |
|
|
8
|
+
| **grain** | **String** | | [optional] |
|
|
9
|
+
| **object_type** | **String** | | [optional] |
|
|
10
|
+
| **id** | **String** | | [optional] |
|
|
11
|
+
| **scope** | [**BiomarkerAssayEvidenceResponseScope**](BiomarkerAssayEvidenceResponseScope.md) | | [optional] |
|
|
12
|
+
| **columns** | [**Array<DatasetColumn>**](DatasetColumn.md) | | |
|
|
13
|
+
| **rows** | [**Array<DrugVariantsRow>**](DrugVariantsRow.md) | | |
|
|
14
|
+
| **total** | **Integer** | The exact count of the filtered rows on an ungrouped read, carried by the cursor; null when grouped. | [optional] |
|
|
15
|
+
| **next_cursor** | **String** | | [optional] |
|
|
16
|
+
| **sort** | **Array<String>** | | [optional] |
|
|
17
|
+
| **filters** | **Array<Hash<String, Object>>** | | [optional] |
|
|
18
|
+
| **group_by** | **Array<String>** | | [optional] |
|
|
19
|
+
| **measures** | **Array<String>** | | [optional] |
|
|
20
|
+
| **attribution** | [**Array<DatasetAttribution>**](DatasetAttribution.md) | | [optional] |
|
|
21
|
+
| **source_credit** | **String** | | [optional] |
|
|
22
|
+
| **withheld_tiers** | **Array<String>** | | [optional] |
|
|
23
|
+
| **withheld_columns** | **Array<String>** | | [optional] |
|
|
24
|
+
| **freshness** | [**BiomarkerAssayEvidenceResponseFreshness**](BiomarkerAssayEvidenceResponseFreshness.md) | | [optional] |
|
|
25
|
+
| **build** | [**BiomarkerAssayEvidenceResponseBuild**](BiomarkerAssayEvidenceResponseBuild.md) | | [optional] |
|
|
26
|
+
| **build_state** | [**DatasetBuildState**](DatasetBuildState.md) | | [optional] |
|
|
27
|
+
| **restriction** | **Hash<String, Object>** | | [optional] |
|
|
28
|
+
|
|
29
|
+
## Example
|
|
30
|
+
|
|
31
|
+
```ruby
|
|
32
|
+
require 'pharmaobservatory'
|
|
33
|
+
|
|
34
|
+
instance = PharmaObservatory::DrugVariantsResponse.new(
|
|
35
|
+
dataset: null,
|
|
36
|
+
grain: null,
|
|
37
|
+
object_type: null,
|
|
38
|
+
id: null,
|
|
39
|
+
scope: null,
|
|
40
|
+
columns: null,
|
|
41
|
+
rows: null,
|
|
42
|
+
total: null,
|
|
43
|
+
next_cursor: null,
|
|
44
|
+
sort: null,
|
|
45
|
+
filters: null,
|
|
46
|
+
group_by: null,
|
|
47
|
+
measures: null,
|
|
48
|
+
attribution: null,
|
|
49
|
+
source_credit: null,
|
|
50
|
+
withheld_tiers: null,
|
|
51
|
+
withheld_columns: null,
|
|
52
|
+
freshness: null,
|
|
53
|
+
build: null,
|
|
54
|
+
build_state: null,
|
|
55
|
+
restriction: null
|
|
56
|
+
)
|
|
57
|
+
```
|
|
58
|
+
|
|
@@ -0,0 +1,38 @@
|
|
|
1
|
+
# PharmaObservatory::DrugVariantsRow
|
|
2
|
+
|
|
3
|
+
## Properties
|
|
4
|
+
|
|
5
|
+
| Name | Type | Description | Notes |
|
|
6
|
+
| ---- | ---- | ----------- | ----- |
|
|
7
|
+
| **molecule_id** | **String** | The molecule key: the resolved drug a brand, a salt form or an investigational arm resolves to, and the entry key for the drugs object type. A member id (a salt or a folded trial arm) is not a value here; it redirects to its molecule. | [optional] |
|
|
8
|
+
| **member_id** | **String** | The id of the folded drug record: the drug_id other datasets carry. | [optional] |
|
|
9
|
+
| **member_name** | **String** | The folded record's display name. | [optional] |
|
|
10
|
+
| **role** | **String** | single for a one-to-one fold; component_of_compound for a combination arm listing the molecule. | [optional] |
|
|
11
|
+
| **method** | **String** | How the fold was made (for example rxnorm_synonym, unii_synonym, brand, override, registered_substance). | [optional] |
|
|
12
|
+
| **tier** | **Integer** | The resolver tier that made the fold (1 to 4); 4 is the model backstop. | [optional] |
|
|
13
|
+
| **confidence** | **Float** | The resolver's confidence for the method, from 0 to 1. | [optional] |
|
|
14
|
+
| **member_trials** | **Integer** | Registered trials of the member record. | [optional] |
|
|
15
|
+
| **member_max_phase** | **Integer** | The member's highest development phase. | [optional] |
|
|
16
|
+
| **member_approved** | **Boolean** | True when the member is approved somewhere. | [optional] |
|
|
17
|
+
| **member_biologic** | **Boolean** | True when the member is a biologic substance. | [optional] |
|
|
18
|
+
|
|
19
|
+
## Example
|
|
20
|
+
|
|
21
|
+
```ruby
|
|
22
|
+
require 'pharmaobservatory'
|
|
23
|
+
|
|
24
|
+
instance = PharmaObservatory::DrugVariantsRow.new(
|
|
25
|
+
molecule_id: null,
|
|
26
|
+
member_id: null,
|
|
27
|
+
member_name: null,
|
|
28
|
+
role: null,
|
|
29
|
+
method: null,
|
|
30
|
+
tier: null,
|
|
31
|
+
confidence: null,
|
|
32
|
+
member_trials: null,
|
|
33
|
+
member_max_phase: null,
|
|
34
|
+
member_approved: null,
|
|
35
|
+
member_biologic: null
|
|
36
|
+
)
|
|
37
|
+
```
|
|
38
|
+
|